Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Insomnia is highly prevalent in coronary heart disease (CHD) patients. However, the potential effect of insomnia on the risk of recurrent major adverse cardiovascular events (MACE) remains uncertain. Purpose To estimate the prospective association of insomnia and the risk of recurrent MACE in a CHD population from routine clinical practice. Methods This prospective cohort study included 1082 consecutive patients 2-36 (mean 16) months after a myocardial infarction and/or a coronary revascularization procedure. Data on insomnia, coronary risk factors and comorbidity were collected at baseline. Insomnia was assessed by Bergen insomnia scale (BIS), based on sleep symptoms per week during the past three months. BIS is constructed from the clinical diagnostic criteria for primary insomnia in DSM-IV TR. The primary composite endpoint of MACE defined as cardiovascular death, hospitalization due to myocardial infarction, revascularization, stroke or heart failure was obtained from the hospital records on average 4.2 (SD 0.3) years after the baseline study. Data were analysed using Cox proportional hazard regression on a multiple imputated dataset stratified by prior coronary events. Results At baseline, mean age was 62 (range 31-80) years, 21% were females, 90% were revascularized, 47% had participated in cardiac rehabilitation and the prescription rate of antiplatelets (97%) and statins (93%) were high. A total of 364 MACE (21%, 95% CI 19%-24%) occurred in 225 patients, including 39 CV deaths. Almost half of the patients (45%) suffered from insomnia at baseline and 24% used sleep medication the past week. For insomnia, the relative risk (RR) of recurrent MACE was 1.62 (95% confidence interval (CI) 1.24-2.11, p-value<0.001) in age and gender adjusted analysis, 1.49 (95% CI 1.14, 1.97, p-value=0.004) in analysis also adjusted for coronary risk factors and 1.48 (95% CI 1.12, 1.96, p-value=0.006) in a multi-adjusted analysis including age, gender, coronary risk factors and cardiovascular comorbidity. When also adjusted for symptoms of anxiety and depression the RR of insomnia on recurrent MACE remained significant at 1.41 (95% CI 1.05, 1.89, p-value=0.023). Insomnia accounted for 16% of the MACE in attributable risk fraction analyses, being third in importance after smoking (27%) and low physical activity (21%). Obstructive sleep apnea (Berlin Questionnaire) was not associated with recurrent MACE. Conclusions Insomnia was associated with increased risk of recurrent MACE in this prospective cohort following CHD patients from routine clinical practice. The association remained significant even after adjustments for the major coronary risk factors, comorbidity and symptoms of anxiety and depression, indicating that the effects of insomnia is not mediated through poor risk factor control and other psychosocial factors alone. These results emphasize the importance of identifying patients with insomnia as part of coronary rehabilitation.

The Effects of Insomnia and Sleep Loss on Cardiovascular Disease

Effects of sleep and insomnia on cardiovascular disease - literature review

Hazards of Insomnia and the Effects of Acupuncture Treatment on Insomnia

Insomnia is an factor aggravaging the course of cardiovascular diseases: modern understanding of the problem and ways of solution

Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias

Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study

Insomnia with Physiological Hyperarousal is Associated with Hypertension

Insomnia and Risk of Mortality from All-Cause, Cardiovascular Disease, and Cancer: Systematic Review and Meta-Analysis of Prospective Cohort Studies

Sleep Deficiency and Cardiometabolic Disease

Associations between insomnia and cardiovascular diseases: a meta-review and meta-analysis of observational and Mendelian randomization studies

0333 INSOMNIA WITH OBJECTIVE SHORT SLEEP DURATION IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR AND/OR CEREBROVASCULAR DISEASE

Insomnia with objective short sleep duration is associated with hypertension

Connecting insufficient sleep and insomnia with metabolic dysfunction

The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis

Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies

Cardiovascular Risk Factors for the Diagnosis of Insomnia in End-Stage Renal Disease

Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients

Role of sleep disorders in patients with cardiovascular disease: A systematic review

Insomnia Symptoms and Risk of Cardiovascular Diseases among 0.5 Million Adults

Insomnia with objective but not subjective short sleep duration is associated with incident cardiovascular and/or cerebrovascular disease

Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort.